Clinical trials: Biochemical Relapse Fo Malignant Neoplasm of Prostate
Prostate Cancer, Biochemical Relapse Fo Malignant Neoplasm of Prostate
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.
- Conditions
- Prostate Cancer, Biochemical Relapse Fo Malignant Neoplasm of Prostate, Prostate Adenocarcinoma, Prostate Cancer Recurrent
- Trial name
- PSICHE (NCT05022914)
- Where
- Italy
- Volunteers
- 180 people
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
Biochemical Relapse Fo Malignant Neoplasm of Prostate
18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.
Prostate cancer (PCa) is the fifth-most common cancer for male with a seventh highest cancer-related death in Taiwan. Currently, the incidence and mortality rate are still increasing rapidly.
- Trial name
- NCT05048537
- Testing
- 18F-FACBC PET/CT
- Where
- Taiwan
- Volunteers
- 20 people
- Sponsor
- National Taiwan University Hospital